Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 2
2020 3
2021 2
2022 4
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
TGF-β3 in differentiation and function of Tph-like cells and its relevance to disease activity in patients with systemic lupus erythematosus.
Shan Y, Nakayamada S, Nawata A, Yamagata K, Sonomoto K, Tanaka H, Satoh-Kanda Y, Nguyen MP, Todoroki Y, Nagayasu A, Ueno M, Kanda R, Fujita Y, Zhang T, Hao H, Zhou J, Ma X, Anan J, Nguyen AP, Tanaka Y. Shan Y, et al. Among authors: todoroki y. Rheumatology (Oxford). 2023 Jul 5;62(7):2464-2474. doi: 10.1093/rheumatology/keac646. Rheumatology (Oxford). 2023. PMID: 36370078
An enhanced mitochondrial function through glutamine metabolism in plasmablast differentiation in systemic lupus erythematosus.
Sumikawa MH, Iwata S, Zhang M, Miyata H, Ueno M, Todoroki Y, Nagayasu A, Kanda R, Sonomoto K, Torimoto K, Lee S, Nakayamada S, Yamamoto K, Okada Y, Tanaka Y. Sumikawa MH, et al. Among authors: todoroki y. Rheumatology (Oxford). 2022 Jul 6;61(7):3049-3059. doi: 10.1093/rheumatology/keab824. Rheumatology (Oxford). 2022. PMID: 34730825
Pathological role of activated mTOR in CXCR3+ memory B cells of rheumatoid arthritis.
Iwata S, Zhang M, Hajime M, Ohkubo N, Sonomoto K, Torimoto K, Kitanaga Y, Trimova G, Todoroki Y, Miyata H, Ueno M, Nagayasu A, Kanda R, Nakano K, Nakayamada S, Sakata K, Tanaka Y. Iwata S, et al. Among authors: todoroki y. Rheumatology (Oxford). 2021 Nov 3;60(11):5452-5462. doi: 10.1093/rheumatology/keab229. Rheumatology (Oxford). 2021. PMID: 33693564
mTOR activation in CD8+ cells contributes to disease activity of rheumatoid arthritis and increases therapeutic response to TNF inhibitors.
Zhang M, Iwata S, Sonomoto K, Ueno M, Fujita Y, Anan J, Miyazaki Y, Ohkubo N, Sumikawa MH, Todoroki Y, Miyata H, Nagayasu A, Kanda R, Hao H, Trimova G, Lee S, Nakayamada S, Sakata K, Tanaka Y. Zhang M, et al. Among authors: todoroki y. Rheumatology (Oxford). 2022 Jul 6;61(7):3010-3022. doi: 10.1093/rheumatology/keab834. Rheumatology (Oxford). 2022. PMID: 34791054
Biological/targeted synthetic DMARDs do not arrest bone loss in patients with rheumatoid arthritis: a multicenter prospective observational study.
Sonomoto K, Nakayamada S, Fujino Y, Miyata H, Kubo S, Fujita Y, Inoue Y, Matsunaga S, Iwata S, Hanami K, Todoroki Y, Yoshinari-Korekoda H, Kawabe A, Yamaguchi A, Ueno M, Satoh-Kanda Y, Kanda R, Funada M, Ohkubo N, Kusaka K, Kosaka S, Nagayasu A, Fukuyo S, Nawata M, Miyazaki Y, Tokunaga M, Tanaka K, Okada Y, Tanaka Y. Sonomoto K, et al. Among authors: todoroki y. Rheumatology (Oxford). 2023 Nov 2:kead579. doi: 10.1093/rheumatology/kead579. Online ahead of print. Rheumatology (Oxford). 2023. PMID: 37934120
17 results